CN103191372A - 用于治疗脓毒血症的中药组合物及其制备方法 - Google Patents
用于治疗脓毒血症的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN103191372A CN103191372A CN2013101297167A CN201310129716A CN103191372A CN 103191372 A CN103191372 A CN 103191372A CN 2013101297167 A CN2013101297167 A CN 2013101297167A CN 201310129716 A CN201310129716 A CN 201310129716A CN 103191372 A CN103191372 A CN 103191372A
- Authority
- CN
- China
- Prior art keywords
- weight portions
- radix
- fructus
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 120
- 239000000203 mixture Substances 0.000 title claims abstract description 79
- 206010040047 Sepsis Diseases 0.000 title claims abstract description 58
- 238000002360 preparation method Methods 0.000 title claims description 15
- 238000011282 treatment Methods 0.000 claims abstract description 63
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 23
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 23
- 238000002347 injection Methods 0.000 claims description 31
- 239000007924 injection Substances 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 27
- 238000009835 boiling Methods 0.000 claims description 26
- 229940079593 drug Drugs 0.000 claims description 25
- 239000009636 Huang Qi Substances 0.000 claims description 23
- 241000237903 Hirudo Species 0.000 claims description 22
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims description 21
- 235000006226 Areca catechu Nutrition 0.000 claims description 21
- 244000080767 Areca catechu Species 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 20
- 235000014347 soups Nutrition 0.000 claims description 15
- 238000010438 heat treatment Methods 0.000 claims description 13
- 238000001914 filtration Methods 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 9
- 239000002552 dosage form Substances 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 230000001954 sterilising effect Effects 0.000 claims description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 230000006870 function Effects 0.000 abstract description 11
- 230000002757 inflammatory effect Effects 0.000 abstract description 10
- 208000024891 symptom Diseases 0.000 abstract description 10
- 230000008718 systemic inflammatory response Effects 0.000 abstract description 6
- 230000034994 death Effects 0.000 abstract description 5
- 210000000056 organ Anatomy 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 3
- 244000235603 Acacia catechu Species 0.000 abstract description 2
- 239000002158 endotoxin Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 235000006020 Acacia catechu Nutrition 0.000 abstract 1
- 244000001632 Acorus gramineus Species 0.000 abstract 1
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 244000003416 Asparagus officinalis Species 0.000 abstract 1
- 235000005340 Asparagus officinalis Nutrition 0.000 abstract 1
- 241000045403 Astragalus propinquus Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 244000228957 Ferula foetida Species 0.000 abstract 1
- 241000545744 Hirudinea Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000972673 Phellodendron amurense Species 0.000 abstract 1
- 244000046146 Pueraria lobata Species 0.000 abstract 1
- 235000010575 Pueraria lobata Nutrition 0.000 abstract 1
- 240000004274 Sarcandra glabra Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 240000001949 Taraxacum officinale Species 0.000 abstract 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 abstract 1
- 239000001560 acacia catechu Substances 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 239000009910 sargent gloryvine Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 61
- 210000004369 blood Anatomy 0.000 description 59
- 230000000694 effects Effects 0.000 description 47
- 210000004185 liver Anatomy 0.000 description 24
- 231100000614 poison Toxicity 0.000 description 24
- 230000007812 deficiency Effects 0.000 description 23
- 239000002574 poison Substances 0.000 description 21
- 210000004072 lung Anatomy 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 18
- 230000036407 pain Effects 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 210000002216 heart Anatomy 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 13
- 230000001717 pathogenic effect Effects 0.000 description 13
- 206010011224 Cough Diseases 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 230000017531 blood circulation Effects 0.000 description 9
- 208000011580 syndromic disease Diseases 0.000 description 9
- 208000002173 dizziness Diseases 0.000 description 8
- 230000014759 maintenance of location Effects 0.000 description 8
- 230000008506 pathogenesis Effects 0.000 description 8
- 208000015220 Febrile disease Diseases 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 7
- 239000010839 body fluid Substances 0.000 description 7
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 208000000059 Dyspnea Diseases 0.000 description 5
- 206010013975 Dyspnoeas Diseases 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 230000008485 antagonism Effects 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 208000015181 infectious disease Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 206010000077 Abdominal mass Diseases 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 4
- 206010013935 Dysmenorrhoea Diseases 0.000 description 4
- 208000010201 Exanthema Diseases 0.000 description 4
- 208000008454 Hyperhidrosis Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 208000025747 Rheumatic disease Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 208000019790 abdominal distention Diseases 0.000 description 4
- 231100000540 amenorrhea Toxicity 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 231100000284 endotoxic Toxicity 0.000 description 4
- 230000002346 endotoxic effect Effects 0.000 description 4
- 201000005884 exanthem Diseases 0.000 description 4
- 230000023597 hemostasis Effects 0.000 description 4
- 230000004054 inflammatory process Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000000552 rheumatic effect Effects 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 231100000111 LD50 Toxicity 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000009205 Tinnitus Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000023555 blood coagulation Effects 0.000 description 3
- 208000013116 chronic cough Diseases 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 239000003527 fibrinolytic agent Substances 0.000 description 3
- 230000003480 fibrinolytic effect Effects 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 210000000265 leukocyte Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 210000003800 pharynx Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000002207 retinal effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 231100000886 tinnitus Toxicity 0.000 description 3
- 239000003440 toxic substance Substances 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010003011 Appendicitis Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010010071 Coma Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 206010025421 Macule Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 2
- 208000031971 Yin Deficiency Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000005779 cell damage Effects 0.000 description 2
- 208000037887 cell injury Diseases 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 208000013219 diaphoresis Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 210000000887 face Anatomy 0.000 description 2
- 208000024756 faint Diseases 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000010247 heart contraction Effects 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000008676 import Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 210000003516 pericardium Anatomy 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000036391 respiratory frequency Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 230000028527 righting reflex Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 206010003084 Areflexia Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241001269238 Data Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 206010056325 Faecaloma Diseases 0.000 description 1
- 208000008415 Fecal Impaction Diseases 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018275 Gingival atrophy Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000019395 Lactation disease Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 206010028470 Mycoplasma infections Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 206010034240 Pelvic congestion Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 240000004350 Prunus spinosa Species 0.000 description 1
- 235000010829 Prunus spinosa Nutrition 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010041954 Starvation Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042576 Suppressed lactation Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 208000009257 Visceral Prolapse Diseases 0.000 description 1
- 206010063840 Visceroptosis Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000670 adrenergic alpha-2 receptor antagonist Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000010523 cascade reaction Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229940124446 critical care medicine Drugs 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 208000017574 dry cough Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 201000005562 gingival recession Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000013210 hematogenous Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000003118 histopathologic effect Effects 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000001616 monocyte Anatomy 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 238000004848 nephelometry Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000003448 neutrophilic effect Effects 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003950 pathogenic mechanism Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000035778 pathophysiological process Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 description 1
- 201000005665 thrombophilia Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003556 vascular endothelial cell Anatomy 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | n | 治愈 | 显效 | 有效 | 无效 | 总有效率(%) |
治疗组 | 55 | 14(25.5) | 23(41.8) | 12(21.8) | 6(10.9) | 49(89.1) |
对照组 | 50 | 8(16.0) | 17(34.0) | 15(30.0) | 10(20.0) | 40(80.0) |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310129716.7A CN103191372B (zh) | 2013-04-15 | 2013-04-15 | 用于治疗脓毒血症的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310129716.7A CN103191372B (zh) | 2013-04-15 | 2013-04-15 | 用于治疗脓毒血症的中药组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103191372A true CN103191372A (zh) | 2013-07-10 |
CN103191372B CN103191372B (zh) | 2014-07-02 |
Family
ID=48714305
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310129716.7A Expired - Fee Related CN103191372B (zh) | 2013-04-15 | 2013-04-15 | 用于治疗脓毒血症的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103191372B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104510896A (zh) * | 2014-12-03 | 2015-04-15 | 王玉春 | 一种治疗多器官衰竭的中药配方 |
CN104524263A (zh) * | 2014-12-12 | 2015-04-22 | 山东新希望六和集团有限公司 | 一种用于治疗羊黑疫的药物组合物及其制备方法 |
CN104940635A (zh) * | 2015-07-16 | 2015-09-30 | 王艳娣 | 一种烫烧伤外用中药组合物 |
CN105796881A (zh) * | 2016-04-08 | 2016-07-27 | 广州暨南生物医药研究开发基地有限公司 | 一种含有艾叶的治疗脓毒症的药物组合物及其制备方法 |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2622745C2 (ru) * | 2015-08-31 | 2017-06-19 | Энту Фармасьютикалс Лтд | Композиции на основе биоресурсов для профилактики или лечения сепсиса и/или связанных с сепсисом осложнений и состояний, способы профилактики и лечения сепсиса |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1380098A (zh) * | 2002-05-20 | 2002-11-20 | 张勇飞 | 一种抗感染复合制剂及其制备方法 |
CN1457855A (zh) * | 2003-05-17 | 2003-11-26 | 王若斋 | 阴毒清源丹 |
CN101537141A (zh) * | 2008-03-21 | 2009-09-23 | 北京中泰天和科技有限公司 | 一种清热解毒、疏风消肿、利咽通窍的药物组合 |
CN102349991A (zh) * | 2011-05-29 | 2012-02-15 | 王红芳 | 一种杀病毒防流感的组合物及该组合物所制成的防感冒贴 |
CN102363008A (zh) * | 2011-10-18 | 2012-02-29 | 王若斋 | 阴毒清源丹 |
-
2013
- 2013-04-15 CN CN201310129716.7A patent/CN103191372B/zh not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1380098A (zh) * | 2002-05-20 | 2002-11-20 | 张勇飞 | 一种抗感染复合制剂及其制备方法 |
CN1457855A (zh) * | 2003-05-17 | 2003-11-26 | 王若斋 | 阴毒清源丹 |
CN101537141A (zh) * | 2008-03-21 | 2009-09-23 | 北京中泰天和科技有限公司 | 一种清热解毒、疏风消肿、利咽通窍的药物组合 |
CN102349991A (zh) * | 2011-05-29 | 2012-02-15 | 王红芳 | 一种杀病毒防流感的组合物及该组合物所制成的防感冒贴 |
CN102363008A (zh) * | 2011-10-18 | 2012-02-29 | 王若斋 | 阴毒清源丹 |
Non-Patent Citations (8)
Title |
---|
何瑛等: "早期大剂量应用参附注射液在治疗剂型脓毒血症中的作用", 《中国中医急症》, vol. 22, no. 1, 31 January 2013 (2013-01-31), pages 99 - 100 * |
孙治霞等: "血必净对30例血滤后脓毒血症患者内毒素清除效应的临床观察", 《中医研究》, vol. 25, no. 3, 31 March 2012 (2012-03-31), pages 30 - 32 * |
张廉君: "脓毒血症患者26例临床治疗体会", 《湖南中医药大学学报》, vol. 32, no. 12, 31 December 2012 (2012-12-31), pages 31 - 32 * |
李文中: ""银黄青蒲汤"治疗外伤继发脓毒血症", 《四川中医》, vol. 2, 30 June 1984 (1984-06-30), pages 374 * |
林朱森等: "地塞米松联用血必净辅助治疗脓毒血症临床观察", 《中国医药导刊》, vol. 13, no. 5, 31 December 2011 (2011-12-31), pages 834 - 835 * |
王丽霞等: "脓毒血症1例分析", 《中国误诊学杂志》, vol. 9, no. 3, 31 January 2009 (2009-01-31), pages 725 * |
赵宇等: "活血化瘀法治疗脓毒血症42例疗效观察", 《辽宁中医杂志》, vol. 34, no. 3, 31 December 2007 (2007-12-31), pages 302 - 303 * |
陈树榕: ""毒血症、败血症、脓毒血症"的中医辨证论治", 《福建医药杂志》, 30 June 1980 (1980-06-30), pages 49 - 51 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104510896A (zh) * | 2014-12-03 | 2015-04-15 | 王玉春 | 一种治疗多器官衰竭的中药配方 |
CN104524263A (zh) * | 2014-12-12 | 2015-04-22 | 山东新希望六和集团有限公司 | 一种用于治疗羊黑疫的药物组合物及其制备方法 |
CN104940635A (zh) * | 2015-07-16 | 2015-09-30 | 王艳娣 | 一种烫烧伤外用中药组合物 |
CN105796881A (zh) * | 2016-04-08 | 2016-07-27 | 广州暨南生物医药研究开发基地有限公司 | 一种含有艾叶的治疗脓毒症的药物组合物及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103191372B (zh) | 2014-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102793822B (zh) | 一种治疗阑尾炎的药物及其制备方法 | |
CN103550517B (zh) | 一种治疗肝癌的药物 | |
CN103520572B (zh) | 一种用于治疗特应性皮炎的中药组合物及其制备方法 | |
CN103191372B (zh) | 用于治疗脓毒血症的中药组合物及其制备方法 | |
CN103169923B (zh) | 一种治疗心肌炎的中药组合物及其制备方法 | |
CN101721528B (zh) | 一种治疗慢性前列腺炎的药物组合物 | |
CN102671061B (zh) | 用于治疗慢性化脓性中耳炎的中药、应用及制备方法 | |
CN102210777B (zh) | 一种用于防治脓毒症的中药组合物及其制备方法 | |
CN102949571B (zh) | 一种治疗慢性骨髓炎的药物 | |
CN105106749A (zh) | 一种普外科治疗痔疮的中药组合物 | |
CN102935176B (zh) | 一种用于慢性咽喉炎的含化颗粒及制备方法 | |
CN105169018A (zh) | 一种普外科治疗痔疮的中药组合物 | |
CN102973876B (zh) | 一种用于治疗病理性白带过多的药物 | |
CN105106696A (zh) | 一种治疗慢性前列腺炎的中药组合物 | |
CN104888178A (zh) | 一种治疗小儿腹泻的中药 | |
CN100409885C (zh) | 一种治疗外阴硬化性苔癣的药物 | |
CN104840864B (zh) | 一种治疗小儿脾虚型腹泻的中药制剂 | |
CN102716341B (zh) | 治疗急性消化性溃疡出血的中药组合物及其制备方法 | |
CN103028028B (zh) | 一种治疗原发性肝癌的中药 | |
CN102362957B (zh) | 一种治疗深部红斑狼疮的中成药 | |
CN106620408A (zh) | 一种治疗恶性葡萄胎的药物及其制备方法 | |
CN105582190A (zh) | 一种用于胃热痰瘀型肥胖的中药及其制备方法 | |
CN105213975A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN105288095A (zh) | 一种治疗糖尿病的中药组合物及其制备方法 | |
CN103638400B (zh) | 一种治疗口干口渴的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: CAO BINGYU Free format text: FORMER OWNER: LIU RONGQIANG Effective date: 20140523 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Cao Bingyu Inventor after: Liu Shubin Inventor after: Zhou Xinwei Inventor after: Yu Fang Inventor after: Chen Fang Inventor before: Liu Rongqiang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272000 JINING, SHANDONG PROVINCE TO: 271200 TAIAN, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LIU RONGQIANG TO: CAO BINGYU LIU SHUBIN ZHOU XINWEI YU FANG CHEN FANG |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20140523 Address after: 271200 Xintai Xintai people's Hospital, Taishan Medical University, 1329 Xin Fu Road, Shandong, Tai'an, Xintai, China Applicant after: Cao Bingyu Address before: 272000 Shandong city of Jining province Huai Road No. 79 Jining district two Affiliated Hospital of the medical ICU Applicant before: Liu Rongqiang |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140702 Termination date: 20170415 |